Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2023 | Exploring the potential of NK cells in mitigating relapse after allogeneic transplantation

Joseph McGuirk • 24 Apr 2023
EBMT 2023
General NK-Cell Therapy

Joseph McGuirk, DO, The University of Kansas Medical Center, Kansas City, KS, comments on the possibility of using natural killer (NK) cells to mitigate relapse after transplant. This interview took place at the 49th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) held in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Envision, Kite, AlloVir, BMS, Novartis, CRISPR, Nektar, Caribou Bio, Sana Technologies, Legend Biotech

More from Joseph McGuirk

CMV reactivation after matched unrelated donor & haploidentical transplantation
3:12
CMV reactivation after matched unrelated donor & haploidentical transplantation
Joseph McGuirk • 24 Apr 2023
Phase I study of donor-derived γδ T cells as relapse prophylaxis post haplo/cy
2:16
Phase I study of donor-derived γδ T cells as relapse prophylaxis post haplo/cy
Joseph McGuirk • 24 Apr 2023
CARBON: results of Phase I study of CTX110 allogeneic CRISPR-CAS9-engineered CAR-Ts in R/R LBCL
5:32
CARBON: results of Phase I study of CTX110 allogeneic CRISPR-CAS9-engineered CAR-Ts in R/R LBCL
Joseph McGuirk • 24 Apr 2023

Related Videos

Key principles for implementing AI tools into clinical practice
3:19
Key principles for implementing AI tools into clinical practice
Adrián Mosquera Orgueira • 24 Sep 2026
Current role of AI in hematology/oncology: separating the hype from reality
2:54
Current role of AI in hematology/oncology: separating the hype from reality
Adrián Mosquera Orgueira • 24 Sep 2026
Addressing the risk of over-reliance on AI for clinical decision-making
2:25
Addressing the risk of over-reliance on AI for clinical decision-making
Adrián Mosquera Orgueira • 24 Sep 2026
Telomere dynamics in normal and pathological aging
12:41
Telomere dynamics in normal and pathological aging
Coleman Lindsley • 18 Sep 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals